Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Ramberger, Melanie ^a   Peschl, Patrick ^a   Schanda, Kathrin ^a   Irschick, Regina ^a   Höftberger, Romana ^b,c   Deisenhammer, Florian ^a   Rostásy, Kevin ^d   Berger, Thomas ^a   Dalmau, Josep ^c   Reindl, Markus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ADULT; AGED; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; CELL LINE; CELL SURFACE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOFLUORESCENCE MICROSCOPY; INTERMETHOD COMPARISON; MALE; PROTEIN EXPRESSION; RELIABILITY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; ADOLESCENT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; FLUORESCENCE MICROSCOPY; HEK293 CELL LINE; IMMUNOLOGY; PROCEDURES; SEROLOGY;

RATTUS;

ADOLESCENT; ADULT; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; FEMALE; FLOW CYTOMETRY; HEK293 CELLS; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; RECEPTORS, N-METHYL-D-ASPARTATE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84929484606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122037     Document Type: Article

References (31)

1. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-Daspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61(1):25-36. PMID: 17262855
2. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005; 58(4):594-604. PMID: 16178029
3. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009; 66(1):11-8. doi: 10.1002/ana. 21756 PMID: 19670433
4. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2):157-65. doi: 10.1016/S1474-4422(12)70310-1 PMID: 23290630
5. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12):1091-8. doi: 10. 1016/S1474-4422(08)70224-2 PMID: 18851928
6. Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology. 2014; 82(7):556-63. doi: 10.1212/WNL.0000000000000126 PMID: 24443452
7. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010; 133(Pt 6):1655-67.
8. Graus F, Saiz A, Lai M, Bruna J, Lopez F, Sabater L, et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology. 2008; 71(12):930-6. doi: 10.1212/01.wnl. 0000325917.48466.55 PMID: 18794496
9. Pruss H, Dalmau J, Harms L, Holtje M, Ahnert-Hilger G, Borowski K, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010; 75(19):1735-9. doi: 10. 1212/WNL.0b013e3181fc2a06 PMID: 21060097
10. Armangue T, Titulaer MJ, Malaga I, Bataller L, Gabilondo I, Graus F, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr. 2013; 162(4):850-6 e2. doi: 10.1016/j.jpeds.2012.10.011 PMID: 23164315
11. Suleiman J, Wright S, Gill D, Brilot F, Waters P, Peacock K, et al. Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia. 2013; 54(12):2091-100. doi: 10.1111/epi.12405 PMID: 24151870
12. Suleiman J, Brilot F, Lang B, Vincent A, Dale RC. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia. 2013; 54(6):1036-45. doi: 10.1111/epi.12142 PMID: 23551014
13. Hacohen Y, Wright S, Waters P, Agrawal S, Carr L, Cross H, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosur Ps. 2013; 84(7):748-55. doi: 10.1136/ jnnp-2012-303807 PMID: 23175854
14. Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009; 66(5):704-9. doi: 10.1002/ana.21807 PMID: 19938173
15. Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol. 2011; 231(1-2):86-91. doi: 10.1016/j.jneuroim.2010.09.013 PMID: 20965577
16. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014; 13(2):167-77. doi: 10.1016/S1474-4422(13)70282-5 PMID: 24360484
17. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol. 2001; 11(3):327-35. PMID: 11399431
18. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Science's STKE: signal transduction knowledge environment. 2004; 2004(255):re16. PMID: 15494561
19. Gleichman AJ, Spruce LA, Dalmau J, Seeholzer SH, Lynch DR. Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci. 2012; 32(32):11082-94. doi: 10.1523/JNEUROSCI.0064-12.2012 PMID: 22875940
20. Di Pauli F, Mader S, Rostasy K, Schanda K, Bajer-Kornek B, Ehling R, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol. 2011; 138(3):247-54. doi: 10. 1016/j.clim.2010.11.013 PMID: 21169067
21. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010; 10(12):835-44. doi: 10.1016/S1473-3099(10)70222-X PMID: 20952256
22. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012; 54(7):899-904. doi: 10.1093/cid/cir1038 PMID: 22281844
23. Suh-Lailam BB, Haven TR, Copple SS, Knapp D, Jaskowski TD, Tebo AE. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay. Clin Chim Acta. 2013; 421:1-6. doi: 10.1016/j.cca.2013.02.010 PMID: 23454475
24. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012; 135(Pt 11):3453-68.
25. McIlhinney RA, Le Bourdelles B, Molnar E, Tricaud N, Streit P, Whiting PJ. Assembly intracellular targeting and cell surface expression of the human N-methyl-D-aspartate receptor subunits NR1a and NR2A in transfected cells. Neuropharmacology. 1998; 37(10-11):1355-67.
26. Meddows E, Le Bourdelles B, Grimwood S, Wafford K, Sandhu S, Whiting P, et al. Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors. J Biol Chem. 2001; 276(22):18795-803. PMID: 11279200
27. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010; 30(17):5866-75. doi: 10.1523/JNEUROSCI.0167- 10.2010 PMID: 20427647
28. Planaguma J, Leypoldt F, Mannara F, Gutierrez-Cuesta J, Martin-Garcia E, Aguilar E, et al. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain. 2015; 138(Pt 1):94-109.
29. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10(1):63-74. doi: 10.1016/S1474-4422(10)70253-2 PMID: 21163445
30. Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, et al. Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol. 2014; 76(1):82-94. doi: 10.1002/ana. 24189 PMID: 24853231
31. Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL, et al. Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. J Neurol Neurosurg Ps. 2014 Sep 22. pii: jnnp-2014-308736. doi: 10.1136/jnnp-2014-308736 [Epub ahead of print]